Serum Osteoprotegerin in Prevalent Hemodialysis Patients: Associations With Mortality, Atherosclerosis and Cardiac Function

BMC Nephrology - United Kingdom
doi 10.1186/s12882-017-0701-8
Full Text
Abstract

Available in full text

Categories
Nephrology
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Relation Between High Serum Hepcidin-25 Level and Subclinical Atherosclerosis and Cardiovascular Mortality in Hemodialysis Patients

Anatolian journal of cardiology
Cardiovascular MedicineCardiology
2018English

Time-Dependent Associations Between Iron and Mortality in Hemodialysis Patients

Journal of the American Society of Nephrology : JASN
MedicineNephrology
2005English

C-Reactive Protein and Prediction of 1-Year Mortality in Prevalent Hemodialysis Patients

Clinical Journal of the American Society of Nephrology
EpidemiologyNephrologyCritical CareTransplantationIntensive Care Medicine
2011English

Addition of Novel Biomarkers for Predicting All-Cause and Cardiovascular Mortality in Prevalent Hemodialysis Patients

Therapeutic Apheresis and Dialysis
HematologyNephrology
2017English

Association of CKD-MBD Markers With All-Cause Mortality in Prevalent Hemodialysis Patients: A Cohort Study in Beijing

PLoS ONE
Multidisciplinary
2017English

AB0733 Associations of Serum Osteoprotegerin and Il-18 Concentrations With Cardiovascular Risk in Ankylosing Spondylitis and Psoriatic Arthritis Patients

2017English

Serum Sclerostin Is an Independent Predictor of Mortality in Hemodialysis Patients

BMC Nephrology
Nephrology
2014English

Osteoprotegerin as a Marker of Atherosclerosis in Diabetic Patients

International Journal of Endocrinology
EndocrineEndocrinologyMetabolismAutonomic SystemsDiabetes
2013English

Poverty and Mortality in Hemodialysis Patients

Journal of the American Society of Nephrology : JASN
MedicineNephrology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy